Litcius/Paper detail

Combination of talaporfin photodynamic therapy and Poly (ADP-Ribose) polymerase (PARP) inhibitor in gastric cancer

Mamoru Tanaka, Makiko Sasaki, Taketo Suzuki, Hirotada Nishie, Hiromi Kataoka

2020Biochemical and Biophysical Research Communications26 citationsDOI

Topics & Concepts

OlaparibPARP inhibitorPARP1Cancer researchPhotodynamic therapyPoly ADP ribose polymerasePhotosensitizerCancerDNA damageCancer cellChemistryBiologyMedicinePolymeraseDNAInternal medicineBiochemistryPhotochemistryOrganic chemistryPARP inhibition in cancer therapyDNA Repair Mechanisms
Combination of talaporfin photodynamic therapy and Poly (ADP-Ribose) polymerase (PARP) inhibitor in gastric cancer | Litcius